Animal models Etiology M3243AG MYB Transcriptome Disease susceptibility Auto-immunité Cellules th17 Mass cytometry CyTOF Conduction disease Autoimmune diseases Experimental autoimmune myasthenia gravis Experimental models AChR antibodies Genetic associations Immune regulation Cytokines Gd T cells Neuromuscular junction Interferon de type I COX2 Immunology and Microbiology Section FMR1 Autoimmune disease Early-onset myasthenia gravis Myasthénie grave Interleukine-23 Human myoblasts MiR-125 Interferonopathy Acetylcholine receptors Inflammation Immune response Exercise Experimental mouse models Germinal centers Interferon type-I Anticorps monoclonal Cardiomyopathy Innate immunity Macrophages DICER Myoblasts CXCL13-CXCR5 Ectopic germinal centers Centres germinatifs ectopiques PBMC Acides nucléiques endogènes Autoimmunity Inflammation Neuromuscular junction Germinal centers Th17 Muscle regeneration Myasthenia Gravis MG Immunity Quality of life Interferon Immunotherapy COVID-19 Thymic epithelial cells B cells MiR-7 Aldehyde dehydrogenase biological marker CD31 antigen CD34 antigen CD45 antigen CD56 antigen adipocyte animal experiment animal model animal tissue antigen expression article cell differentiation cell function cell isolation cell labeling cell population cell selection controlled study endomysium enrichment culture enzyme activity enzyme substrate flow cytometry human human cell human tissue immunofluorescence in vitro study in vivo study mouse muscle biopsy muscle contraction muscle injury nonhuman phenotype skeletal muscle stem cell transplantation Adipogenesis Aldehyde Dehydrogenase Cell Differentiation Cells Cultured Flow Cytometry Humans Immunohistochemistry Muscle Cells Muscle Development Muscle Skeletal Phenotype Clinical cell transplantation Germinal center Chronicity Inflammatory cytokines CTCF Max Gender MG patients Myasthenia gravis Interféron de type I Complete Freund's adjuvant Interferon-β Long-term follow-up Experimental autoimmune myasthenia gravis EAMG Maladie auto-immune Endogenous nucleic acids Chronic inflammation Chemokines Adaptive immunity CCL21 Heart failure Interferon type I Antimir-150 Acetylcholine receptor Interleukin 23 Thymoma Thymus Th17 cells Lamin A/C nuclei Glucocorticoids Il-23 BAFF Autoimmunity Fragile X syndromes Acetylcholine receptor antibodies Genetics Ferrites Interferon IFN LMNA Chemokine CD31